The conversations surrounding artificial intelligence (AI) and its scope to transform the pharma industry have been underway for a while…
As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is…
In a promising new chapter, Algorae Pharmaceuticals (ASX: 1AI), formerly known as Living Cell Technologies (ASX: LCT), has debuted its…